Yu X, Ni Z, Wang Y, Wang J, Deng G, Shi J
Sci China Life Sci. 2025; .
PMID: 39985647
DOI: 10.1007/s11427-024-2856-y.
Yu J, Liu C, Qu X, Gao X, Liu Y
Front Cell Infect Microbiol. 2025; 14:1516806.
PMID: 39902183
PMC: 11788155.
DOI: 10.3389/fcimb.2024.1516806.
He L, Zhang Y, Si K, Yu C, Shang K, Yu Z
BMC Genomics. 2024; 25(1):1249.
PMID: 39725881
PMC: 11673856.
DOI: 10.1186/s12864-024-11152-x.
Tramuto F, Maida C, Randazzo G, Previti A, Sferlazza G, Graziano G
Viruses. 2024; 16(10).
PMID: 39459976
PMC: 11512306.
DOI: 10.3390/v16101644.
Lin Y, Wang Y, Li H, Liu T, Zhang J, Guo X
Emerg Microbes Infect. 2024; 13(1):2396864.
PMID: 39331815
PMC: 11441081.
DOI: 10.1080/22221751.2024.2396864.
ProcCluster and procaine hydrochloride inhibit the replication of influenza A virus .
Haring C, Schroeder J, Jungwirth J, Loffler B, Henke A, Engert B
Front Microbiol. 2024; 15:1422651.
PMID: 39206370
PMC: 11350405.
DOI: 10.3389/fmicb.2024.1422651.
Gene editing of pigs to control influenza A virus infections.
Kwon T, Artiaga B, McDowell C, Whitworth K, Wells K, Prather R
Emerg Microbes Infect. 2024; 13(1):2387449.
PMID: 39083026
PMC: 11346336.
DOI: 10.1080/22221751.2024.2387449.
Anti-hemagglutinin monomeric nanobody provides prophylactic immunity against H1 subtype influenza A viruses.
Barbieri E, Sosa-Holt C, Ibanez L, Baztarrica J, Garaicoechea L, Gay C
PLoS One. 2024; 19(7):e0301664.
PMID: 38985719
PMC: 11236207.
DOI: 10.1371/journal.pone.0301664.
Epistasis mediates the evolution of the receptor binding mode in recent human H3N2 hemagglutinin.
Lei R, Liang W, Ouyang W, Hernandez Garcia A, Kikuchi C, Wang S
Nat Commun. 2024; 15(1):5175.
PMID: 38890325
PMC: 11189414.
DOI: 10.1038/s41467-024-49487-4.
H19 influenza A virus exhibits species-specific MHC class II receptor usage.
Karakus U, Mena I, Kottur J, El Zahed S, Seoane R, Yildiz S
Cell Host Microbe. 2024; 32(7):1089-1102.e10.
PMID: 38889725
PMC: 11295516.
DOI: 10.1016/j.chom.2024.05.018.
Potential pandemic risk of circulating swine H1N2 influenza viruses.
Le Sage V, Rockey N, French A, McBride R, McCarthy K, Rigatti L
Nat Commun. 2024; 15(1):5025.
PMID: 38871701
PMC: 11176300.
DOI: 10.1038/s41467-024-49117-z.
Preparation and characterization of mouse-derived monoclonal antibodies against the hemagglutinin of the H1N1 influenza virus.
Lin X, Yang F, Yan S, Wu H, Wang P, Zhao Y
Virus Res. 2024; 345:199402.
PMID: 38772446
PMC: 11156778.
DOI: 10.1016/j.virusres.2024.199402.
Ultrapotent influenza hemagglutinin fusion inhibitors developed through SuFEx-enabled high-throughput medicinal chemistry.
Kitamura S, Lin T, Lee C, Takamura A, Kadam R, Zhang D
Proc Natl Acad Sci U S A. 2024; 121(22):e2310677121.
PMID: 38753503
PMC: 11145270.
DOI: 10.1073/pnas.2310677121.
The Influenza A Virus Replication Cycle: A Comprehensive Review.
Carter T, Iqbal M
Viruses. 2024; 16(2).
PMID: 38400091
PMC: 10892522.
DOI: 10.3390/v16020316.
Gene editing of pigs to control influenza A virus infections.
Kwon T, Artiaga B, McDowell C, Whitworth K, Wells K, Prather R
bioRxiv. 2024; .
PMID: 38293027
PMC: 10827075.
DOI: 10.1101/2024.01.15.575771.
Unveiling the role of host kinases at different steps of influenza A virus life cycle.
Dey S, Mondal A
J Virol. 2024; 98(1):e0119223.
PMID: 38174932
PMC: 10805039.
DOI: 10.1128/jvi.01192-23.
Rapid and sensitive detection of SARS-CoV-2 virus in human saliva samples using glycan based nanozyme: a clinical study.
Rokni M, Bastami T, Meshkat Z, Rahimi H, Zibaee S, Meshkat M
Mikrochim Acta. 2023; 191(1):36.
PMID: 38108890
DOI: 10.1007/s00604-023-06120-3.
A Single Oral Immunization with a Replication-Competent Adenovirus-Vectored Vaccine Protects Mice from Influenza Respiratory Infection.
Goffin E, Du X, Hemmi S, Machiels B, Gillet L
J Virol. 2023; 97(7):e0013523.
PMID: 37338377
PMC: 10373536.
DOI: 10.1128/jvi.00135-23.
Structural characterisation of hemagglutinin from seven Influenza A H1N1 strains reveal diversity in the C05 antibody recognition site.
Ghafoori S, Petersen G, Conrady D, Calhoun B, Stigliano M, Baydo R
Sci Rep. 2023; 13(1):6940.
PMID: 37117205
PMC: 10140725.
DOI: 10.1038/s41598-023-33529-w.
Intradermal Immunization of Soluble Influenza HA Derived from a Lethal Virus Induces High Magnitude and Breadth of Antibody Responses and Provides Complete Protection In Vivo.
Raj S, Vishwakarma P, Saxena S, Kumar V, Khatri R, Kumar A
Vaccines (Basel). 2023; 11(4).
PMID: 37112692
PMC: 10141624.
DOI: 10.3390/vaccines11040780.